P11836 (CD20_HUMAN) Homo sapiens (Human)
B-lymphocyte antigen CD20 UniProtKBInterProSTRINGInteractive Modelling
297 aa; Sequence (Fasta) ; (Isoform 2)
Available Structures
8 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Structure of full-length CD20 in complex with Ofatumumab Fab |
Heteromer | 6×Y01; | ||||
| Assess | ||||||
| Structure of full-length CD20 in complex with Rituximab Fab |
Heteromer | 8×Y01; 2×PC1; 10×MYS; | ||||
| Assess | ||||||
| Structure of full-length CD20 in complex with Obinutuzumab Fab |
Heteromer | |||||
| Assess | ||||||
| Structure of full-length CD20 in complex with Obinutuzumab Fab |
Heteromer | |||||
| Assess | ||||||
| Structure of CD20 in complex with rituximab Fab |
Heteromer | 6×Y01; | ||||
| Assess | ||||||
| Epitope characterization and crystal structure of GA101 provide insights into the molecular basis f… |
Heteromer | 1×CL; | ||||
| Assess | ||||||
| Crystal structure of Rituximab Fab in complex with an epitope peptide |
Heteromer | |||||
| Assess | ||||||
| Crystal Structure of Chimeric Antibody C2H7 Fab in complex with a CD20 Peptide |
Heteromer | |||||
| Assess | ||||||
1 SWISS-MODEL model
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 6vja.1.A | monomer | 0.64 | 2×Y01; | 100.00 | ||
| Assess | ||||||